Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |